Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 1991 May;41(5):780-98.
doi: 10.2165/00003495-199141050-00007.

Azelaic Acid. A Review of Its Pharmacological Properties and Therapeutic Efficacy in Acne and Hyperpigmentary Skin Disorders

Affiliations
Review

Azelaic Acid. A Review of Its Pharmacological Properties and Therapeutic Efficacy in Acne and Hyperpigmentary Skin Disorders

A Fitton et al. Drugs. .

Abstract

Azelaic acid is a naturally occurring saturated dicarboxylic acid which, on topical application (usually as a 20% cream), has been shown to be effective in the treatment of comedonal acne and inflammatory (papulopustular, nodular and nodulocystic) acne, as well as various cutaneous hyperpigmentary disorders characterised by hyperactive/abnormal melanocyte function, including melasma and, possibly, lentigo maligna. In addition, azelaic acid has an antiproliferative and cytotoxic effect on the human malignant melanocyte, and preliminary findings indicate that it may arrest the progression of cutaneous malignant melanoma. The mechanism of this selective cytotoxic action of azelaic acid is unclear, but may possibly be related to its inhibition of mitochondrial oxidoreductase activity and DNA synthesis. In controlled studies, topical azelaic acid demonstrated comparable anti-acne efficacy to topical tretinoin, benzoyl peroxide, erythromycin and oral tetracycline, while in patients with melasma azelaic acid proved at least as effective as topical hydroquinone. On topical application azelaic acid is well tolerated, with adverse effects apparently limited to a generally mild and transient local cutaneous irritation. Thus, topical azelaic acid, employed either as monotherapy or in combination with other treatments, is likely to prove of value in the management of acne and several hyperpigmentary disorders, most notably melasma.

Similar articles

See all similar articles

Cited by 20 articles

See all "Cited by" articles

References

    1. Clin Chim Acta. 1979 Nov 15;99(1):71-83 - PubMed
    1. J Am Acad Dermatol. 1983 Feb;8(2):200-3 - PubMed
    1. Acta Derm Venereol Suppl (Stockh). 1989;143:62-6 - PubMed
    1. Clin Dermatol. 1989 Apr-Jun;7(2):106-19 - PubMed
    1. Invest Ophthalmol Vis Sci. 1989 Mar;30(3):491-8 - PubMed

MeSH terms

LinkOut - more resources

Feedback